| Views | |
|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 129 |
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease | 11 | 4 | 5 | 4 | 9 | 2 | 5 |
| Views | |
|---|---|
| Gruzdeva_Risk management.pdf | 77 |
| Views | |
|---|---|
| United States | 40 |
| Canada | 14 |
| Germany | 5 |
| South Korea | 3 |
| Australia | 2 |
| China | 2 |
| Spain | 2 |
| India | 2 |
| Japan | 2 |
| Qatar | 2 |
| Views | |
|---|---|
| Ottawa | 13 |
| San Francisco | 5 |
| Houston | 4 |
| Englewood | 3 |
| Palo Alto | 3 |
| Doha | 2 |
| Fairfield | 2 |
| Hanoi | 2 |
| Kanda | 2 |
| Mumbai | 2 |